Medical Equipment

The Rise Of Innovative Hidden-Needle Lancing Devices Enhancing Safety And Comfort In Blood Sampling Is Influencing The Lancet Market

April 14, 2026April 14, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Is The Projected Increase In Market Value Of The Lancet Market During 2026–2030?

The lancet market has experienced rapid expansion in recent years. It is projected to increase from $2.8 billion in 2025 to $3.11 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 11.1%. The growth observed in the preceding period can be attributed to several factors, including the rising prevalence of diabetes, improvements in hospital infrastructure, enhanced awareness surrounding blood testing, the demand for point-of-care diagnostics, and the ongoing development of safety lancets.

The lancet market is projected to experience substantial expansion in the coming years, with its valuation set to reach $4.71 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 10.9%. This anticipated growth is driven by factors such as enhanced technological innovations in lancet design, the wider acceptance of homecare testing solutions, the incorporation of digital health platforms, market expansion into developing regions, and greater regulatory backing for safety-focused devices. Key developments during this period are expected to encompass the miniaturization of medical equipment, a heightened emphasis on patient safety, the increasing prevalence of home healthcare, the expansion of point-of-care diagnostic methods, and the emergence of environmentally friendly and sustainable medical tools.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/report/lancet-global-market-report

Which Strong Drivers Are Impacting The Lancet Market Growth?

The increasing incidence of diabetes is projected to drive the expansion of the lancet market in the foreseeable future. Diabetes, a long-term health issue, impacts the body’s energy conversion from food, stemming from issues with insulin generation or utilization. This rise in diabetes cases is largely attributed to unhealthy lifestyle choices, including inadequate nutrition, insufficient exercise, and rising obesity rates, all of which foster insulin resistance and higher blood glucose levels. Lancets aid in diabetes management by facilitating consistent blood glucose monitoring via safe and accurate fingertip pricking, a crucial practice for successful diabetes control, prompt identification of glucose changes, and opportune modifications to treatment, diet, or lifestyle to avert complications. For example, data from June 2024, sourced from the National Health Service, a UK government body, indicated that in 2023, the NHS identified an extra 549,000 individuals in England at risk of developing type 2 diabetes. This brought the total number of individuals with non-diabetic hyperglycemia, or pre-diabetes, registered with a GP to 3,615,330. This marks a substantial increase when compared to 3,065,825 recorded in 2022, demonstrating an almost 20% rise. Consequently, the increasing prevalence of diabetes is a key driver for the expansion of the lancet market.

How Is The Lancet Market Segmented Across Different Segment Categories?

The lancet market covered in this report is segmented –

1) By Type: Safety Lancet, Push Button Safety Lancet, Pressure Activated Safety Lancet, Side Button Safety Lancet, Personal Lancet

2) By Gauze Size: 22 Gauze And Below, 23 Gauze –33 Gauze, Above 33 Gauze

3) By Application: Glucose Testing, Hemoglobin Testing, Coagulation Testing, Cholesterol Testing, Allergy Testing, Neonatal Testing, Other Applications

4) By End User: Hospitals, Clinics, Ambulatory Surgery Centers, Homecare Settings, Other End Users

Subsegments:

1) By Safety Lancet: Needle Lancet, Blade Lancet, Microneedle Safety Lancets

2) By Push Button Safety Lancet: Fixed Depth Push Button Lancet, Adjustable Depth Push Button Lancet

3) By Pressure Activated Safety Lancet: Contact Activated Lancet, Spring-Loaded Pressure Lancet

4) By Side Button Safety Lancet: Retractable Needle Side Button Lancet, Non-Retractable Needle Side Button Lancet

5) By Personal Lancet: Reusable Personal Lancet, Single-Use Personal Lancet

Which Trends Are Contributing To Changes In The Lancet Market?

Major companies in the lancet market are concentrating on employing innovative technologies, such as total path control vertical-drive technology, to enhance sampling accuracy and lessen pain during blood collection. This particular technology is a mechanism designed to guide the lancet needle along a direct, vertical trajectory during both insertion and retraction. This regulated movement minimizes sideways motion, thereby decreasing tissue damage, vibration, and discomfort, which ultimately provides a more precise and pleasant blood sampling experience for the user. As an illustration, in July 2025, SteriLance Medical (Suzhou) Inc., a medical device company based in China, introduced its OneStep lancing device and SoftSense lancets in Spain. This offering presented a cap-free, hidden-needle lancing solution that incorporates patent-protected total path control vertical-drive technology to enable virtually painless blood sampling and improve user safety. The one-step device incorporates a four-step sequence—insert, twist, press, and eject—which simplifies the lancing procedure by reducing preparatory actions by roughly 70% compared to traditional lancing pens.

Which Organizations Play A Role In The Lancet Market Landscape?

Major companies operating in the lancet market are Cardinal Health Inc., F. Hoffmann-La Roche Ltd, Abbott Laboratories, Becton Dickinson and Company, Terumo Corporation, SARSTEDT AG & Co. KG, B. Braun Melsungen AG, Owen Mumford Limited, Amkay Products Pvt. Ltd, NARANG MEDICAL LIMITED, GBUK GROUP LIMITED, ARKRAY HEALTHCARE PRIVATE LIMITED, Sterimed Medical Devices Private Limited, MediPurpose Pte. Ltd, Carelife USA Inc., Shandong Lianfa Medical Plastic Products Co. Ltd, Ambimed Healthcare Private Limited, Greiner Bio-One International GmbH, Roche Diabetes Care GmbH, Ypsomed Holding AG, TaiDoc Technology Corporation, HTL STREFA S.A.

Get The Full Lancet Market Report:

https://www.thebusinessresearchcompany.com/report/lancet-global-market-report

Which Region Leads The Lancet Market In Terms Of Market Share?

North America was the largest region in the lancet market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the lancet market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Lancet Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/lancet-global-market-report

Browse Through More Reports Similar to the Global Lancet Market 2026, By The Business Research Company

Sports Medicine Market Report 2026

https://www.thebusinessresearchcompany.com/report/sports-medicine-global-market-report

Cardiovascular Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/cardiovascular-devices-global-market-report

Cardiovascular Drugs Market Report 2026

https://www.thebusinessresearchcompany.com/report/cardiovascular-drugs-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795